Table 3.
Lung inflammatory genes that are significantly affected during severe AKI
Gene Title | Gene Symbol | Fold Change
|
PubMatrix
|
|
---|---|---|---|---|
6 h | 36 h | Lung Inflammation | ||
Significant at 6-h timepoint | ||||
chemokine (C-C motif) ligand 9 | Ccl9 | 4.11 | 1.86b | 0 |
leukocyte immunoglobulin-like receptor B3 | Lilrb3 | 3.63 | 1.80 | 0 |
thrombospondin 1 | Thbs1 | 3.48 | 1.28 | 3 |
CD14 antigen | Cd14 | 3.21 | 1.71 | 30 |
CCAAT/enhancer binding protein (C/EBP), beta | Cebpb | 2.99 | 1.98 | 1 |
phospholipase A2, group VII | Pla2g7 | 2.91 | 5.60 | 0 |
Fc receptor, IgE, high affinity I, gamma | Fcer1g | 2.81 | 2.97 | 0 |
serum amyloid A 2 | Saa2 | 2.59 | 1.32 | 12 |
fatty acid binding protein 4, adipocytea | Fabp4 | −2.51 | −2.44 | 0 |
roundabout homolog 1 | Robo1 | −2.69 | −1.45 | 0 |
Significant at both timepoints | ||||
serum amyloid A 3 | Saa3 | 15.99 | 6.42 | 3 |
chemokine (C-X-C motif) ligand 2 | Cxcl2 | 14.67 | 2.69 | 17 |
IL-1 receptor, type II | Il1r2 | 5.88 | 11.34 | 0 |
inhibin beta-B | Inhbb | 6.93 | 3.70 | 0 |
serum amyloid A 1 | Saa1 | 5.91 | 2.45 | 9 |
suppressor of cytokine signaling 3 | Socs3 | 5.47 | 2.41 | 0 |
chemokine orphan receptor 1 | Cmkor1 | 3.57 | 3.71 | 1 |
chemokine (C-C motif) receptor 1 | Ccr1 | 2.73 | 3.76 | 2 |
formyl peptide receptor, related sequence 2 | Fpr-rs2 | 2.76 | 3.72 | 0 |
interleukin 4 receptor, alpha | Il4ra | 2.42 | 3.87 | 4 |
Significant at 36-h timepoint | ||||
serine/cysteine peptidase inhibitor, clade A 3N | Serpina3n | 2.03 | 7.72 | 0 |
lipocalin 2 | Lcn2 | 1.64 | 5.81 | 3 |
FMS-like tyrosine kinase 1 | Flt1 | 1.65 | 4.59 | 0 |
arachidonate 5-lipoxygenase activating protein | Alox5ap | 2.29 | 3.80 | 0 |
S100 calcium binding protein A9 | S100a9 | 1.55 | 3.57 | 6 |
chemokine (C-C motif) ligand 6 | Ccl6 | 2.30 | 3.09 | 0 |
signal transducer and activator of transcription 3 | Stat3 | 1.99 | 3.04 | 9 |
peptidoglycan recognition protein 1 | Pglyrp1 | 1.37 | 2.83 | 0 |
IL-1 receptor-like 1 | Il1rl1 | −1.20 | −2.70 | 3 |
chemokine (C-X-C motif) ligand 12 | Cxcl12 | −1.82 | −3.57 | 2 |
Significance criteria: 2.38 fold change and 2% false discovery rate (see Concise Methods).
Significantly affected after 30 min of ischemia (Figure 5A);
failed significance testing.